Trihexyphenidyl Hydrochloride NDC 61748-054

NDC codes

FDA NDC Directory

Product NDC (as listed)61748-054Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61748-0054Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61748-054-16	61748005416	473 mL in 1 BOTTLE, PLASTIC (61748-054-16)Marketed from Mar 1, 2001

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trihexyphenidyl Hydrochloride
Generic name (nonproprietary): trihexyphenidyl hydrochloride
Active ingredients: Trihexyphenidyl hydrochloride — 2 mg/5mL
Dosage form: Syrup
Route: Oral
Labeler: Akorn
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040251
Marketing start: Mar 1, 2001
Listing expires: Dec 31, 2026
Identifiers: Product ID 61748-054_3a17b358-46b6-4e74-9788-ccb8acf9ca8fSPL ID 3a17b358-46b6-4e74-9788-ccb8acf9ca8fSPL set ID 294cd88d-d9e8-4938-b4be-c3adc4a35de0RxCUI 905273UNII AO61G82577

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461748005416 followed by a unit qualifier and the quantity

Package 61748-0054-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 21, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Trihexyphenidyl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040251

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040251
Product	Strength	Form · route	Labeler	Product NDC
Trihexyphenidyl Hydrochloride	Trihexyphenidyl hydrochloride 2 mg/5mL	SolutionOral	Chartwell RX, LLC	62135-065